Kratom laws in Massachusetts allow you to buy, possess, and sell kratom at the state level. The plant and its two main alkaloids, mitragynine and 7-hydroxymitragynine, do not appear in any schedule of the Massachusetts Controlled Substances Act, so there are no state criminal penalties tied to it.1Mass.gov. Mass. General Laws c.94C – Controlled Substances Act The complications sit elsewhere: individual cities and towns are starting to regulate sales, bills in the current legislative session would add statewide rules, and the FDA is pushing to schedule concentrated kratom-derived products at the federal level.
Kratom Is Not a Controlled Substance in Massachusetts
Chapter 94C of the Massachusetts General Laws is the state’s controlled substances statute, and neither kratom nor its alkaloids are listed anywhere in it.1Mass.gov. Mass. General Laws c.94C – Controlled Substances Act Buying kratom powder, capsules, or extract from a retailer or having it shipped to a Massachusetts address is not a criminal act under current state law.
What the state does not do is regulate the product. There is no statewide minimum purchase age. There are no mandatory potency tests. There are no kratom-specific labeling standards. If you pick up a bag of kratom in Massachusetts, nothing in state law guarantees the alkaloid content matches the label or that the product is free of other substances.
Local Rules Vary by City and Town
The bigger practical issue for a Massachusetts buyer or seller is that municipalities can regulate kratom on their own, and a growing number do. Marshfield, for example, publishes a dedicated kratom regulation through its public health department.2Town of Marshfield, MA. Kratom Regulation Other communities have adopted their own rules, and no single public list tracks all of them.
Boston may soon join. In March 2026, City Councilor John FitzGerald announced plans to draft a proposal aimed at kratom in the city. His stated concern is synthetic products containing concentrated 7-hydroxymitragynine. The proposal would ban synthetic versions outright and could require age verification at the point of sale for natural kratom. City officials noted that neither the Boston Public Health Commission nor the Boston Police Department currently tracks kratom-related incidents, in part because standard drug testing does not detect it.
The result is a patchwork. A product sold openly in one town can be restricted a few miles away. Before opening a retail operation or stocking kratom on your shelves, check with the local board of health where the sale will happen.
Pending Massachusetts Legislation
Two bills in the 194th legislative session address kratom. House Bill 4261, titled “An Act Regulating Kratom Sales in the Commonwealth” and informally called “Ty’s Bill,” was filed as emergency legislation. Its preamble states the purpose is “to prevent deaths with the unregulated sale of Kratom.”3General Court of Massachusetts. Bill H.4261 194th (Current) House No. 5127 also addresses kratom regulation in the current session.
Neither bill has been signed into law as of mid-2026. If you buy or sell kratom in the state, the current session is worth watching, because a statewide framework, if enacted, would likely include age limits, labeling rules, and possibly caps on 7-hydroxymitragynine concentration.
Adulteration and Misbranding Law Still Applies
Kratom sellers are not entirely outside state oversight. Massachusetts General Laws Chapter 94 governs adulterated and misbranded food, drugs, cosmetics, and devices. Under Section 186, a drug is adulterated when its strength, quality, or purity falls below the standard under which it is sold, or when a substance has been mixed in that reduces its quality. Section 187 defines a product as misbranded when its packaging or label carries any false or misleading statement about its contents.4General Court of Massachusetts. Massachusetts General Laws Part I, Title XV, Chapter 94
Section 189A gives the Department of Public Health and local boards of health authority to examine products offered for sale and determine whether they are adulterated or misbranded. If a kratom product contains undisclosed substances, mismatched alkaloid concentrations, or misleading label claims, regulators can tag the product, start proceedings, and pursue penalties.4General Court of Massachusetts. Massachusetts General Laws Part I, Title XV, Chapter 94
Enforcement, in practice, is reactive. Health authorities generally act on consumer complaints or reports of adverse events rather than routine testing. A contaminated or mislabeled product can circulate for a while before anyone intervenes.
Federal Actions That Reach Massachusetts Consumers
FDA Import Alert 54-15
State legality does not fully control what makes it to your door. FDA Import Alert 54-15 authorizes detention of kratom-containing dietary supplements and bulk dietary ingredients at the border without physical examination. The FDA treats kratom as a “new dietary ingredient” because it has no evidence the plant was marketed in the United States before October 15, 1994, and considers kratom products adulterated because there is “inadequate information to provide reasonable assurance that such ingredient does not present a significant or unreasonable risk of illness or injury.”5U.S. Food and Drug Administration. Import Alert 54-15
Practically, some kratom shipments to Massachusetts addresses are stopped. Products from companies on the FDA’s “Red List” are detained automatically, and shipments from other companies can be flagged when they appear to contain kratom marketed as a supplement. The alert was most recently updated in February 2025.5U.S. Food and Drug Administration. Import Alert 54-15
The 7-Hydroxymitragynine Scheduling Push
In July 2025, the FDA recommended that concentrated 7-hydroxymitragynine products be classified as Schedule I under the federal Controlled Substances Act, citing high abuse potential and no approved medical use. The agency also issued warning letters to seven companies marketing 7-OH in tablets, gummies, drink mixes, and shots. The FDA stated it is “specifically targeting 7-OH, a concentrated byproduct of the kratom plant” and is “not focused on natural kratom leaf products.”6U.S. Food and Drug Administration. FDA Takes Steps to Restrict 7-OH Opioid Products Threatening American Consumers
The DEA is reviewing that recommendation. If scheduling is finalized, concentrated 7-OH products would become federally illegal regardless of Massachusetts law. Natural kratom leaf would not be affected by that particular action, but the line between natural leaf products and concentrated 7-OH extracts is not always obvious on a store shelf. Some products sold under the kratom label contain elevated 7-OH, and those could shift from legal to illegal once scheduling takes effect.
Health Considerations Without Regulation
The absence of state rules leaves real gaps for consumers. Products vary in potency, and some have been found to contain contaminants or undisclosed additives. The FDA has flagged risks including respiratory depression, agitation, hallucinations, nausea, and severe withdrawal symptoms.5U.S. Food and Drug Administration. Import Alert 54-15
Because kratom is not a controlled substance and does not show up on standard drug panels, a treating physician may not know a patient is using it unless the patient says so. That matters for drug interactions with prescription medications and for emergency care when symptoms are unexplained. If you use kratom, telling your doctor is the closest thing to a safety net the current legal setup allows.